Comprehensive Review of Olea europaea : A Holistic Exploration into Its Botanical Marvels, Phytochemical Riches, Therapeutic Potentials, and Safety Profile.
Hamza ElhrechOumayma AguerdChaimae El KourchiMonica GalloDaniele NaviglioImane ChamkhiAbdelhakim BouyahyaPublished in: Biomolecules (2024)
Human health is now inextricably linked to lifestyle choices, which can either protect or predispose people to serious illnesses. The Mediterranean diet, characterized by the consumption of various medicinal plants and their byproducts, plays a significant role in protecting against ailments such as oxidative stress, cancer, and diabetes. To uncover the secrets of this natural treasure, this review seeks to consolidate diverse data concerning the pharmacology, toxicology, phytochemistry, and botany of Olea europaea L. ( O. europaea ). Its aim is to explore the potential therapeutic applications and propose avenues for future research. Through web literature searches (using Google Scholar, PubMed, Web of Science, and Scopus), all information currently available on O. europaea was acquired. Worldwide, ethnomedical usage of O. europaea has been reported, indicating its effectiveness in treating a range of illnesses. Phytochemical studies have identified a range of compounds, including flavanones, iridoids, secoiridoids, flavonoids, triterpenes, biophenols, benzoic acid derivatives, among others. These components exhibit diverse pharmacological activities both in vitro and in vivo, such as antidiabetic, antibacterial, antifungal, antioxidant, anticancer, and wound-healing properties. O. europaea serves as a valuable source of conventional medicine for treating various conditions. The findings from pharmacological and phytochemical investigations presented in this review enhance our understanding of its therapeutic potential and support its potential future use in modern medicine.
Keyphrases
- oxidative stress
- human health
- risk assessment
- systematic review
- cardiovascular disease
- wound healing
- type diabetes
- randomized controlled trial
- public health
- current status
- metabolic syndrome
- papillary thyroid
- dna damage
- induced apoptosis
- physical activity
- ischemia reperfusion injury
- machine learning
- squamous cell carcinoma
- electronic health record
- silver nanoparticles
- lymph node metastasis